Toxicity and toxicokinetic assessment of an anti-tubercular drug pretomanid in cynomolgus monkeys

Pretomanid is a nitroimidazooxazine antimycobacterial drug that was approved in more than 10 countries as part of a three-drug, all oral regimen, consisting of bedaquiline, pretomanid, and linezolid (BPaL) for 6-months treatment of adults with pulmonary extensively drug-resistant tuberculosis (XDR-T...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruning-Barry, Rebecca, Ambroso, Jeffrey L., Dillberger, John, Yang, Tian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294187/
https://www.ncbi.nlm.nih.gov/pubmed/35864921
http://dx.doi.org/10.1016/j.toxrep.2022.04.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294187/
https://www.ncbi.nlm.nih.gov/pubmed/35864921
http://dx.doi.org/10.1016/j.toxrep.2022.04.021

Ejemplares similares